Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.

× No keyword cloud information.

75 in total

Review 1. Advancements in pharmacotherapy for angina.

Authors: Ankur Jain; Islam Y Elgendy; Mohammad Al-Ani; Nayan Agarwal; Carl J Pepine
Journal: Expert Opin Pharmacother Date: 2017-03-15 Impact factor: 3.889

Review 2. Excitation-contraction coupling and mitochondrial energetics.

Authors: Christoph Maack; Brian O'Rourke
Journal: Basic Res Cardiol Date: 2007-07-27 Impact factor: 17.165

Review 3. Regulating myocardial blood flow in health and disease.

Authors: Henry Gewirtz
Journal: Curr Cardiol Rep Date: 2009-03 Impact factor: 2.931

Review 4. Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology.

Authors: Yangzhen Shao; Bjorn Redfors; David Benoist; Sigfus Gizurarson; Elmir Omerovic
Journal: Mol Cell Biochem Date: 2014-04-27 Impact factor: 3.396

5. Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable patients with CAD treated with dual ANtiplatelet therapy) study.

Authors: Francesco Pelliccia; Cesare Greco; Carlo Gaudio; Giuseppe Rosano; Cristiana Vitale; Giuseppe Marazzi; Fabiana Rollini; Dominick J Angiolillo
Journal: J Thromb Thrombolysis Date: 2015-10 Impact factor: 2.300

Review 6. THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.

Authors: Anna Grodzinsky; Suzanne V Arnold; Dany Jacob; Boris Draznin; Mikhail Kosiborod
Journal: Endocr Pract Date: 2016-12-14 Impact factor: 3.443

Review 7. Anti-anginal and anti-ischemic effects of late sodium current inhibition.

Authors: Neil J Wimmer; Peter H Stone
Journal: Cardiovasc Drugs Ther Date: 2013-02 Impact factor: 3.727

8. Emerging clinical role of ranolazine in the management of angina.

Authors: David S Vadnais; Nanette K Wenger
Journal: Ther Clin Risk Manag Date: 2010-10-21 Impact factor: 2.423

Review 9. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors: Richard Kones
Journal: Vasc Health Risk Manag Date: 2010-09-07

10. The novel late Na⁺ current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations.

Authors: Sridharan Rajamani; Gongxin Liu; Nesrine El-Bizri; Donglin Guo; Cindy Li; Xiao-Liang Chen; Kristopher M Kahlig; Nevena Mollova; Elfatih Elzein; Jeff Zablocki; Luiz Belardinelli
Journal: Br J Pharmacol Date: 2016-09-14 Impact factor: 8.739

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.